The agent metformin, an inhibitor of mTOR activity [4, 65, 72], can prevent such processes during obesity in experimental mouse models and can reverse the loss of SIRT1 function during inhibition of the circadian components CLOCK and BMAL1 [192]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.